Centers for Disease Control and Prevention (CDC) data show that over 100 million US adults are obese, PwC noted, while an analysis published in JAMA Cardiology in November determined that 137 million Americans may be eligible for the GLP-1 drug semaglutide (prescribed as Wegovy for weight loss and Ozempic for type 2 diabetes)
[4] Richie JP Jr, Nichenametla S, Neidig W, Calcagnotto A, Haley JS, Schell TD, Muscat JE
Theyre short, thin, and widely toleratedideal for both new and experienced users
After menopause, I struggled with weight loss
Infused with hydrating fluids, vitamins, and nutrients, this treatment resets your body clock, boosts energy levels, and promotes rapid recovery